Kensington, MD, United States of America

Hynda K Kleinman

USPTO Granted Patents = 6 


Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2001-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Hynda K Kleinman

Introduction

Hynda K Kleinman, an innovative inventor based in Kensington, MD, has made significant contributions to the fields of medicine and therapeutic treatments. With a total of six patents to his name, his work focuses primarily on the treatment of skin and wound repair, as well as the modulation of angiogenesis in various pathological conditions.

Latest Patents

Kleinman's latest patents include groundbreaking inventions such as the "Treatment of skin and wound repair with thymosin beta 4," and "Therapeutic administration of the scrambled anti-angiogenic peptide C16Y." The first patent emphasizes the composition and methods for skin treatment utilizing thymosin beta 4, which has shown promise in enhancing wound healing. The second patent addresses unregulated angiogenesis, a condition linked to several serious ocular diseases. His discovery of the peptide sequence C16Y, a modified version of C16 from laminin-1, provides new methods for inhibiting ocular neovascularization and tumor growth, showcasing Kleinman’s commitment to advancing medical science.

Career Highlights

Throughout his career, Hynda K Kleinman has worked with prominent organizations, including the United States of America as represented by the Secretary of the Department of Health and Human Services and the Secretary of Health. His research has significantly impacted the development of treatments for conditions driven by abnormal angiogenesis, enriching the scientific and medical communities.

Collaborations

Kleinman has collaborated with esteemed colleagues such as Katherine M Malinda and Allan L Goldstein, further enhancing the depth and breadth of his research endeavors. These partnerships demonstrate Kleinman’s ability to work collaboratively in the pursuit of innovative solutions to complex health issues.

Conclusion

Hynda K Kleinman exemplifies the spirit of innovation, with a focus on therapeutic advancements that address crucial health challenges. His contributions to the understanding and treatment of skin and angiogenesis underscore the vital role inventors play in enhancing human health and wellbeing. As he continues to innovate, the medical field anticipates further advancements stemming from his pioneering work.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…